Literature DB >> 1939596

Detection and differentiation of antibodies to human T-cell lymphotropic virus types I and II by the immunofluorescence method.

D Gallo1, L M Penning, C V Hanson.   

Abstract

We compared the sensitivities of the prototype human T-cell lymphotropic virus type I (HTLV-I)- and HTLV-II-transformed cell lines, MT2 and Mo-T, with that of an HTLV-II-infected cell line, clone 19, established in our laboratory, in the immunofluorescence (IF) test for detection of antibody to HTLV-I and HTLV-II. In addition, IF antibody titers with the three antigens were determined, and the results were compared with HTLV-I and HTLV-II typing by polymerase chain reaction (PCR). The MT2 cell line was more sensitive than the two HTLV-II cell lines for detecting HTLV-I antibody by IF, and clone 19 was more sensitive than Mo-T or MT2 for measuring HTLV-II antibody. In the titration study, the antigen that gave the highest titer correlated completely with the HTLV type determined by PCR, indicating that the relatively simple IF titration method can be used for differentiating HTLV-I and HTLV-II antibody in sera and plasmas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939596      PMCID: PMC270328          DOI: 10.1128/jcm.29.10.2345-2347.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Comparison of Western immunoblot antigens and interpretive criteria for detection of antibody to human T-lymphotropic virus types I and II.

Authors:  D Gallo; J L Diggs; C V Hanson
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

2.  Distinguishing between HTLV-I and HTLV-II by western blot.

Authors:  S Z Wiktor; S S Alexander; G M Shaw; S H Weiss; E L Murphy; R J Wilks; V J Shortly; B Hanchard; W A Blattner
Journal:  Lancet       Date:  1990-06-23       Impact factor: 79.321

3.  Comparison of immunofluorescence, enzyme immunoassay, and Western blot (immunoblot) methods for detection of antibody to human T-cell leukemia virus type I.

Authors:  D Gallo; M N Hoffman; C K Cossen; J L Diggs; J W Hurst; L M Penning
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

4.  Determination of a unique and immunodominant epitope of human T cell lymphotropic virus type I.

Authors:  J J Lipka; K Bui; G R Reyes; R Moeckli; S Z Wiktor; W A Blattner; E L Murphy; G M Shaw; C V Hanson; J J Sninsky
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

5.  High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing.

Authors:  S Kwok; D Gallo; C Hanson; N McKinney; B Poiesz; J J Sninsky
Journal:  AIDS Res Hum Retroviruses       Date:  1990-04       Impact factor: 2.205

6.  Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infection.

Authors:  Y M Chen; T H Lee; S Z Wiktor; G M Shaw; E L Murphy; W A Blattner; M Essex
Journal:  Lancet       Date:  1990-11-10       Impact factor: 79.321

  6 in total
  14 in total

1.  A new and frequent human T-cell leukemia virus indeterminate Western blot pattern: epidemiological determinants and PCR results in central African inhabitants.

Authors:  Claudia Filippone; Sylviane Bassot; Edouard Betsem; Patricia Tortevoye; Micheline Guillotte; Odile Mercereau-Puijalon; Sabine Plancoulaine; Sara Calattini; Antoine Gessain
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

2.  Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in 10 Chilean seronegative patients with tropical spastic paraparesis or HTLV-I-associated myelopathy.

Authors:  E Ramirez; L Cartier; M Rios; J Fernandez
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

3.  African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies.

Authors:  A M Vandamme; M Salemi; M Van Brussel; H F Liu; K Van Laethem; M Van Ranst; L Michels; J Desmyter; P Goubau
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Sensitivities of radioimmunoprecipitation assay and PCR for detection of human T-lymphotropic type II infection.

Authors:  D Gallo; L M Penning; J L Diggs; C V Hanson
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

5.  Comparison of four enzyme immunoassays for detection of human T-cell lymphotropic virus type 2 antibodies.

Authors:  D Gallo; E T Yeh; E S Moore; C V Hanson
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

6.  One-step, multiplex, real-time PCR assay with molecular beacon probes for simultaneous detection, differentiation, and quantification of human T-cell leukemia virus types 1, 2, and 3.

Authors:  Guillaume Besson; Mirdad Kazanji
Journal:  J Clin Microbiol       Date:  2009-02-11       Impact factor: 5.948

7.  Comparison of indirect immunofluorescence and membrane fluorescence assays for the differentiation of antibodies to human immunodeficiency virus types 1 and 2.

Authors:  D Gallo; M N Hoffman; E T Yeh; J R George; C V Hanson
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

8.  Evaluation of two commercial human T-cell lymphotropic virus western blot (immunoblot) kits with problem specimens.

Authors:  D Gallo; J L Diggs; C V Hanson
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

9.  Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009.

Authors:  Yun Brenda Chang; Zhanna Kaidarova; Daniel Hindes; Marjorie Bravo; Nancy Kiely; Hany Kamel; Denise Dubay; Barbara Hoose; Edward L Murphy
Journal:  J Infect Dis       Date:  2013-09-24       Impact factor: 5.226

10.  First human isolate of Hantavirus (Andes virus) in the Americas.

Authors:  Hector Galeno; Judith Mora; Eliecer Villagra; Jorge Fernandez; Jury Hernandez; Gregory J Mertz; Eugenio Ramirez
Journal:  Emerg Infect Dis       Date:  2002-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.